NFE2L2 and ovarian carcinoma: Interestingly, the mRNA expressions of Nrf2 and HO-1 were lower in ovarian cancer than in normal tissues based on the GEPIA database, in contrast to reports of their upregulated protein levels in tumors such as ovarian cancer (48, 49).